FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway
Background/Aims: Fibroblast growth factor receptor 2 (FGFR2) has attracted considerable interest as a therapeutic target in gastric cancer (GC). There is growing evidence to suggest that the bioavailability of the potent pro-tumor function of FGFR2 is associated with thrombospondins (TSPs). As a fol...
Main Authors: | Tingting Huang, Dian Liu, Yihua Wang, Piao Li, Li Sun, Huihua Xiong, Yuhong Dai, Man Zou, Xianglin Yuan, Hong Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-10-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/494590 |
Similar Items
-
FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC
by: Zhang D, et al.
Published: (2019-11-01) -
Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the <i>ESRP1</i><sup>amp</sup>-<i>FGFR2</i><sup>norm</sup>-<i>FGFR2-IIIc</i><sup>high</sup> Axis in Diffuse Gastric Cancer
by: Sara Pinto Teles, et al.
Published: (2019-12-01) -
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
by: Jinglin Zhang, et al.
Published: (2019-06-01) -
The Aberrant Expression of the Mesenchymal Variant of FGFR2 in the Epithelial Context Inhibits Autophagy
by: Monica Nanni, et al.
Published: (2019-06-01) -
Identification of FGFR3-TACC3 gene fusion in metastatic gastric cancer
by: Youjin Kim, et al.
Published: (2017-12-01)